Aug 5, 2026 04:45PM
Aug 4, 2026 04:15PM
May 27, 2026 10:14AM
Mar 27, 2026 07:00AM
Mar 10, 2026 10:19AM
Mar 9, 2026 04:22PM
Mar 9, 2026 12:01PM TD Cowen Reiterates Buy Rating on Editas Medicine (EDIT) following Q4 results
Mar 9, 2026 07:04AM
Jan 19, 2026 02:20AM
Nov 10, 2025 04:35PM
Nov 10, 2025 07:33AM
Oct 31, 2025 09:54AM
Oct 9, 2025 11:01AM
Oct 6, 2025 09:00AM Editas Medicine to present EDIT-401 data at gene therapy congress
Sep 5, 2025 06:47AM
Sep 3, 2025 05:01AM
Sep 2, 2025 07:03AM
Aug 15, 2025 06:52AM
Aug 13, 2025 05:58AM
Aug 12, 2025 05:45PM
Jun 18, 2025 12:15PM CRISPR Therapeutics (CRSP) gains on continued chatter
Jun 17, 2025 11:28AM
May 13, 2025 07:26AM
May 13, 2025 07:06AM
May 13, 2025 04:49AM
May 12, 2025 04:02PM
Mar 20, 2025 04:01PM
Mar 5, 2025 04:52PM Editas Medicine (EDIT) Misses Q4 EPS by 22c
Feb 20, 2025 05:43AM
Jan 13, 2025 09:05AM
Dec 18, 2024 05:09PM
Dec 13, 2024 12:22PM
Dec 13, 2024 08:02AM
Dec 13, 2024 07:15AM
Dec 13, 2024 06:53AM Editas Medicine (EDIT) PT Lowered to $8 at Baird
Dec 13, 2024 03:29AM
Dec 13, 2024 03:27AM
Dec 12, 2024 04:00PM
Dec 11, 2024 05:40AM
Dec 9, 2024 12:00PM
Nov 23, 2024 09:56AM
Nov 6, 2024 11:47AM Evercore ISI Upgrades Editas Medicine (EDIT) to Outperform
Nov 5, 2024 04:19PM
Nov 5, 2024 12:43PM
Nov 5, 2024 06:59AM
Nov 5, 2024 05:23AM
Nov 4, 2024 12:25PM
Nov 4, 2024 07:45AM
Oct 23, 2024 06:36AM Editas Medicine (EDIT) PT Lowered to $9 at Wells Fargo
Oct 22, 2024 01:41PM

432,019 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All